Omada Health is growing revenue rapidly with a perfect 4-quarter earnings beat streak, but the stock is technically overbought, has already exceeded its price target, and notable insider selling adds a cautionary signal.
Thesis pillars
- Strong Revenue Growth→Stable
- Overbought Late Cycle Risk↓Deteriorating
- Notable Insider Selling→Stable
- +2 more pillars — see the Why tab for full reasoning
Pillars as of Jul 5, 2026, based on the 10-K filed Mar 6, 2026
Omada Health, Inc. (OMDA) Stock Analysis
Healthcare · Health Information Services
Wait for pullback to $18.04. Weak momentum; also insider activity concern — blocks BUY_NOW at $18.73. Engine's entry $18.04 (support + ATR (held)) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risk: Elevated risk factors.
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal... Read more
Wait for pullback to $18.04. Weak momentum; also insider activity concern — blocks BUY_NOW at $18.73. Engine's entry $18.04 (support + ATR (held)) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risk: Elevated risk factors. Chart setup: No clear chart pattern; technical signals are mixed. Earnings in 3 days. Wait until post-earnings. Score 6.4/10, moderate confidence.
Passes 5/8 gates (positive momentum, favorable risk/reward ratio, no SEC red flags, semi cycle peak clear, materials cycle peak clear). Fails on earnings proximity 3d<=7d. Suitability: aggressive.
Recent developments
updated 2026-11-02Recent Developments — Omada Health, Inc.
Latest news
- NEWS Wells Fargo Maintains Omada Health(OMDA.US) With Hold Rating, Maintains Target Price $22 - Moomoo — Moomoo neutral
- NEWS Quantinno Capital Management LP Grows Stock Position in Omada Health, Inc. $OMDA - MarketBeat — MarketBeat neutral
- NEWS AlpInvest Partners B.V. Makes New $1.18 Million Investment in Omada Health, Inc. $OMDA - MarketBeat — MarketBeat positive
- NEWS Omada Health (NASDAQ:OMDA) President Sells 8,866 Shares - MarketBeat — MarketBeat negative
- NEWS Omada Health (NASDAQ:OMDA) CAO Craig Gracey Sells 1,042 Shares of Stock - MarketBeat — MarketBeat negative
Generated 2026-11-02T11:33:17Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMCustomerlimited number of customers and channel partners10-K Item 1A: 'A substantial portion of our sales comes from or through a limited number of customers and channel partners that operate as resellers.'
- MEDIUMSupplierlimited number of third-party suppliers10-K Item 1A: 'We depend on a limited number of third-party suppliers for certain devices and other supplies that we deliver to members in connection with our programs'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 ceiling hit
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Wait for pullback to $18.04. Weak momentum; also insider activity concern — blocks BUY_NOW at $18.73. Engine's entry $18.04 (support + ATR (held)) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risk: Elevated risk factors. Chart setup: No clear chart pattern; technical signals are mixed. Earnings in 3 days. Wait until post-earnings. Target $24.51 (+30.9%), stop $16.96 (−10.4%), A.R:R 2.6:1. Score 6.4/10, moderate confidence.
Take-profit target: $24.51 (+30.8% upside). Target $24.51 (+30.9%), stop $16.96 (−10.4%), A.R:R 2.6:1. Stop-loss: $16.96.
Elevated risk factors.
Omada Health, Inc. trades at a P/E of 78.0 (forward 33.7). TrendMatrix value score: 6.2/10. Verdict: Buy (Wait for Entry).
18 analysts cover OMDA with a consensus score of 4.0/5. Average price target: $28.
What does Omada Health, Inc. do?Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the...
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.